Skip to main content
Fig. 6 | BMC Ophthalmology

Fig. 6

From: Long-term outcomes of anti-vascular endothelial growth factor therapy with and without posterior scleral reinforcement on myopic maculopathy in myopic choroidal neovascularization eyes

Fig. 6

Change in visual acuity (percentage of patients) at 24 months in group A and group B. VA improvement was defined as BCVA improvement of more than 2 lines; VA stability was defined as BCVA improvement of less than 2 lines or unchanged; VA decrease was defined as BCVA decrease of 1 line or more

Back to article page

BMC Ophthalmology

ISSN: 1471-2415

Contact us